The method of any one of embodiments 39-42, wherein the medium chain fatty acids are caproic acid (hexanoic acid), enanthic acid (heptanoic acid), caprylic acid (octanoic acid), pelargonic acid (nonanoic acid), capric acid (decanoic acid), undecylenic acid (undec-10-enoic acid), lauric acid (dodecanoic acid), or any combinations thereof
Market Drivers 5.1.2
Ongoing therapy includes monitoring vitamin B12 levels to adjust dosage as needed and ensure optimal treatment results
Ru(II)-OH with a concentration of 50 M was incubated with different concentrations of GSH substrates (250 M, 500 M, 1000 M and 2000 M)
The FDA has issued guidance documents, warning letters, and taken enforcement actions against companies making inappropriate drug claims or selling adulterated products